豚熱ワクチン市場：タイプ別、流通チャネル別、地域別規模、シェア、展望、機会分析、2025年～2032年

豚熱ワクチンの世界市場は、2025年には30億3,240万米ドルと推定され、2032年には45億8,980万米ドルに達すると予測され、2025年から2032年にかけてCAGR6.1％で成長すると予測されています。

図.豚熱ワクチン市場シェア（%）、2025年地域別

豚熱には、古典的豚熱（CSF）とアフリカ豚熱（ASF）の2種類があります。古典的豚熱（CSF）は、豚の感染力が極めて強いウイルス性疾患です。病気の重症度は、ウイルスの株、群れの免疫状態、豚の年齢によって異なります。一方、アフリカ豚熱は感染力が非常に強く、致死的なウイルス病で、家豚と野豚のあらゆる年齢の豚が罹患します。ASFとCSFの急性型はいずれも高い死亡率を引き起こし、最も重症のASFでは死亡率は100%に近づきます。両疾患とも、死亡率の低い軽症型でも発症することがあります。豚の群れで死亡が突然増加した場合、豚熱の可能性が考えられます。ASFとCSFの急性型の臨床症状には、抑うつ、発熱、食欲不振、耳、鼻、四肢の赤、紫、青のしみなどがあります。病気が進行すると、呼吸困難や咳とともに、嘔吐や下痢（ASFの場合は血性下痢）が起こることがあります。これらの病気は、感染した豚との直接の接触や、汚染されたペン、トラック、衣服との接触によって広がります。両疾患とも、豚は長期間にわたり保菌者であり続ける可能性があるため、発生中の豚の移動は制限されなければならないです。

市場力学

啓発キャンペーンを組織することで豚熱の蔓延を防止し、意識を高めるための政府機関による取り組みの増加は、予測期間中の市場成長を促進すると予想されます。例えば、2022年6月、米国農務省（USDA）の動植物検疫局（APHIS）は、米国におけるアフリカ豚熱の導入と蔓延を防止するための新たな取り組みを発表しました。"Protect Our Pigs "と呼ばれるアウトリーチ・啓発キャンペーンを通じて、APHISは、米国の豚人口と豚肉産業を守るための情報とリソースで、商業豚肉生産者、獣医師、豚の所有者を支援します。

本調査の主な特徴

• 本レポートは、世界の豚熱ワクチン市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模を示します。
• さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案マトリクスを説明します。
• また、市場促進要因、抑制要因、機会、新製品の発売や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の豚熱ワクチン市場の主要企業プロファイルを掲載しています。
• 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• この調査レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
• 利害関係者は、世界の豚発熱ワクチン市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
• 影響分析
• 市場動向
• 疫学
• 規制シナリオ
• PEST分析
• 新製品の承認/発売

第4章 世界の豚熱ワクチン市場- コロナウイルス（COVID-19）パンデミックの影響

• 経済への影響
• COVID-19疫学
• 需要と供給の分析

第5章 世界の豚熱ワクチン市場、タイプ別、2020年～2032年

• アフリカ豚熱
• 古典豚熱

第6章 世界の豚熱ワクチン市場、ワクチンタイプ別、2020年～2032年

• 生弱毒化
• キメラ（生弱毒化または不活化）
• サブユニットまたはベクターシステムベース
• レプリコンワクチン

第7章 世界の豚熱ワクチン市場、流通チャネル別、2020年～2032年

• 公共
• 民間

第8章 世界の豚熱ワクチン市場、地域別、2020年～2032年

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• Merck & Co., Inc.（Merck Animal Health）
• Ceva
• Zoetis Services LLC
• Boehringer Ingelheim International GmbH
• Indian Immunologicals Ltd.
• Bioveta, a.s.
• Komipharm
• EC21 Inc.

第10章 アナリストの推奨事項

• 機会
• アナリストの見解
• Coherent Opportunity Map

第11章 セクション

• 参考文献
• 調査手法

Global Swine Fever Vaccine Market is estimated to be valued at USD 3,032.4 Mn in 2025 and is expected to reach USD 4,589.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.

Figure. Swine Fever Vaccine Market Share (%), By Region 2025

There are two types of swine fever - Classical Swine Fever (CSF) and African Swine Fever (ASF). Classical swine fever (CSF) is an extremely contagious viral disease in pigs. The severity of the disease varies with the strain of the virus, the immune status of the herd, and the age of the pig. African swine fever, on the other hand, is a highly contagious and deadly viral disease affecting both domestic and feral swine of all ages. Acute forms of both ASF and CSF can cause high death rates, with mortality approaching 100% in the most severe form of ASF. Both diseases may also occur in milder forms with lower mortality rates. Swine fever could be considered a possibility in case of a sudden increase in deaths in a group of pigs. Clinical signs of acute forms of both ASF and CSF include depression, fever, loss of appetite, and red, purple, or blue blotching of the ears, nose, and limbs. Vomiting and diarrhea (bloody diarrhea for ASF) may occur as the disease progresses, along with breathing difficulties and coughing. The diseases spread through direct contact with infected pigs or contact with contaminated pens, trucks, or clothing. In both diseases, pigs can remain carriers of the disease for long period and therefore moving pigs during an outbreak must be restricted.

Market Dynamics

Increasing efforts by the government bodies to create awareness and prevent the spread of swine fever by organizing awareness campaigns are expected to drive the market growth over the forecast period. For instance, in June 2022, the United States Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) announced new efforts to help prevent the introduction and spread of African swine fever in the U.S. Through an outreach and awareness campaign called "Protect Our Pigs," APHIS will support commercial pork producers, veterinarians, and pig owners with information and resources to help safeguard America's swine population and the pork industry.

Key features of the study:

• This report provides an in-depth analysis of the global swine fever vaccine market, market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global swine fever vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., Komipharm, and EC21 Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global swine fever vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global swine fever vaccine market

Detailed Segmentation:

• Global Swine Fever Vaccine Market, By Type:
  • African Swine Fever
  • Classical Swine Fever
• Global Swine Fever Vaccine Market, By Vaccine Type:
  • Live-Attenuated
  • Chimeric (Live-attenuated or inactivated)
  • Subunit or vector system based
  • Replicon vaccine
• Global Swine Fever Vaccine Market, By Distribution Channel:
  • Public
  • Private
• Global Swine Fever Vaccine Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Merck & Co., Inc. (Merck Animal Health)
  • Ceva
  • Zoetis Services LLC
  • Boehringer Ingelheim International GmbH
  • Indian Immunologicals Ltd.
  • Bioveta, a.s.
  • Komipharm
  • EC21 Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Vaccine Type
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Epidemiology
• Regulatory Scenario
• PEST Analysis
• New Product Approval/Launch

4. Global Swine Fever Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Demand and Supply Analysis

5. Global Swine Fever Vaccine Market, By Type, 2020 - 2032, (US$ Million)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• African Swine Fever
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
• Classical Swine Fever
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

6. Global Swine Fever Vaccine Market, By Vaccine Type, 2020 - 2032, (US$ Million)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Live-Attenuated
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
• Chimeric (Live-attenuated or inactivated)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
• Subunit or vector system based
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
• Replicon vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

7. Global Swine Fever Vaccine Market, By Distribution Channel, 2020 - 2032, (US$ Million)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Public
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
• Private
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

8. Global Swine Fever Vaccine Market, By Region, 2020 - 2032, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, By Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Merck & Co., Inc. (Merck Animal Health)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Ceva
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Zoetis Services LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Boehringer Ingelheim International GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Indian Immunologicals Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bioveta, a.s.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Komipharm
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• EC21 Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. Section

• References
• Research Methodology
• About Us and Sales Contact